High Hopes for Johnson & Johnson’s Covid Vaccine Have Fizzled in the U.S.

Production problems and a brief pause on its use kept the one-dose vaccine from becoming the game changer that health officials across the country believed it would be.

source https://www.nytimes.com/2021/06/18/us/politics/johnson-johnson-covid-vaccine.html